Genomma Lab Internacional S.A.B. de C.V. (BMV: LABB) will release its Third Quarter 2026 earnings results on Wednesday, October 21, 2026, after the Mexican Stock Exchange close. The pharmaceutical and personal care company has scheduled a conference call to discuss these financial outcomes for the following day.

Management will host the investor conference call on Thursday, October 22, 2026, at 11:00 am Mexico City Time. The session aims to provide detailed insights into the company's quarterly performance and strategic updates.

Conference Call Details

The upcoming discussion will feature key members of the Genomma Lab leadership team. Investors can access the webcast via a direct link provided by the company, with an email confirmation required for registration.

Company Profile

Genomma Lab is a leading pharmaceutical and personal care products company in Mexico with an expanding international presence. The firm develops, sells, and markets premium branded products that often lead their respective categories in sales and market share.

The company relies on a combination of new product development, consumer-oriented marketing, broad retail distribution, and a low-cost operating model. Its shares are listed on the Mexican Stock Exchange under the ticker LAB B.

Genomma Lab Internacional, S.A.B. de C.V. will report its Second Quarter 2026 earnings results after the Mexican Stock Exchange (BMV) closes on Wednesday, July 22, 2026. The company has scheduled a conference call to discuss the quarterly financial performance on Thursday, July 23, 2026, at 11 a.m. Mexico City Time. The announcement provides investors and analysts an opportunity to review the company's operational progress during the period.

Conference Call Details

The earnings discussion will feature presentations from Genomma Lab's senior leadership, including Chief Executive Officer Marco Sparvieri and Chief Financial Officer Antonio Zamora. Christianne Ibañez, Investor Relations Officer, will also participate in the proceedings.

Access Information

Interested parties must register in advance to access the webcast. Participants can access the direct link to complete the registration process. Upon successful registration, attendees will receive an email confirmation containing the invitation details to join the call.

Company Overview

Genomma Lab Internacional, S.A.B. de C.V. operates as a leading pharmaceutical and personal care products company in Mexico with a growing international footprint. The firm develops, sells, and markets a broad portfolio of premium branded products, many of which hold leadership positions in their respective categories based on sales and market share. The company's strategy relies on a successful new product development process, consumer-oriented marketing, a wide retail distribution network, and a low-cost, flexible operating model. Its shares are listed on the Mexican Stock Exchange under the ticker "LAB B" (Bloomberg: LABB:MM).